Antioxidant mechanisms of nitric oxide against iron-catalyzed oxidative stress in cells

Antioxidants and Redox Signaling

Volumn 3, Issue 2, 2001, Pages 189-202

  Kagan, Valerian E ^a,b   Kozlov, Andrey V ^c   Tyurina, Yulia Y ^a,d   Shvedova, Anna A ^e   Yalowich, Jack C ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^d RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^e NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HEME; IRON; IRON DERIVATIVE; NITRIC OXIDE; NITROSYL RADICAL; OXOFERRYL ASSOCIATED RADICAL; PROTEIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; COMPLEX FORMATION; HUMAN; IRON KINETICS; LONG TERM EXPOSURE; MOLECULAR INTERACTION; NITROSATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035018487     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601300185160     Document Type: Article

References (73)

1. Aisen P, and Listowsky I. Iron transport and storage proteins. Annn Rev Biochem 49: 357-393, 1980.
2. Aust SD, Morehouse LA, and Thomas CE. Role of metals in oxygen radical reactions. Free Radic Biol Med 1: 3-25, 1985.
3. Aziz N, and Munro HN. Iron regulates ferritin mRNA translation through a segment of its 5′ untranslated region. Proc Natl Acad Sci U S A 84: 8478-8482, 1987.
4. Baron CP, Skibsted LH, and Andersen HJ. Peroxidation of linoleate at physiological pH: hemichrome formation by substrate binding protects against metmyoglobin activation by hydrogen peroxide. Free Radic Biol Med 28: 549-558, 2000.
5. Bloodsworth A, O'Donnell VB, and Freeman BA. Nitric oxide regulation of free radical-and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol 20:1707-1715, 2000.
6. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, and Bernelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 270: 700-703, 1995.
7. Ceccarelli D, Kozlov AV, Gallesi, D, Tomasi A, Giovannini F, and Masini A. The role of desferrioxamine chelatable iron in rat liver mitochondrial dysfunction in chronic dietary iron overload. Bioelectrochem Bioenerg 42: 169-174, 1997.
8. Cooper CE, Green ES, Rice-Evans CA, Davies MJ, and Wrigglesworth JM. A hydrogen-donating monohydroxamate scavenges ferryl myoglobin radicals. Free Radic Res 20: 219-227, 1994.
9. D'Agnillo F, and Chang TM. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase. Free Radic Biol Med 24: 906-912, 1998.
10. Davies MJ. Detection of peroxyl and alkoxyl radicals produced by reaction of hydroperoxides with heme-proteins by electron spin resonance spectroscopy. Biochim Biophys Acta 964: 28-35, 1988.
11. Deterding LJ, Barr DP, Mason RP, and Tomer KB. Characterization of cytochrome c free radical reactions with peptides by mass spectrometry. J Biol Chem 273: 12863-12869, 1998.
12. de Montalembert M. [Iron chelation in 1998] La chelation du fer en 1998. Transfus Clin Biol 5: 353-356, 1998.
13. Domachowske JB. The role of nitric oxide in the regulation of cellular iron metabolism. Biochem Mol Med 60: 1-7, 1997.
14. Domachowske JB, Rafferty SP, Singhania N, Mardiney M 3rd, and Malech HL. Nitric oxide alters the expression of gamma-globin, H-ferritin, and transferrin receptor in human K562 cells at the posttranscriptional level. Blood 88: 2980-2988, 1996.
15. Dragsten PR, Hallaway PE, Hanson GJ, Berger AE, Bernard B, and Hedlund BE. First human studies with a high-molecular-weight iron chelator. J Lab Clin Med 135, 57-65, 2000.
16. Drapier JC, Hirling H, Wietzerbin J, Kaldy P, and Kuhn LC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J 12: 3643-3649, 1993.
17. Elihu N, Anandasbapathy S, and Fishman WH. Chelation therapy in cardiovascular disease: ethyl-enediaminetetraacetic acid, deferoxamine, and dexrazoxane. J Clin Pharmacol 32: 101-105, 1998.
18. Ferrali M, Signorini C, Ciccoli L, Bambagioni S, Rossi V, Pompella A, and Comporti M. Protection of erythrocytes against oxidative damage and autologous immunoglobulin G (IgG) binding by iron chelator fluor-benzoil-pyridoxal hydrazone. Biochem Pharmacol 59: 1365-1373, 2000.
19. Frieden E, and Hsieh HS. Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol Relat Areas Mol Biol 44: 187-236, 1976.
20. Geng YJ, Hellstrand K, Wennmalm A, and Hansson GK. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res 56: 866-874, 1996.
21. Giulivi C, Romero FJ, and Cadenas E The interaction of trolox C, a water-soluble vitamin E analog, with ferrylmyoglobin: reduction of the oxoferryl moiety. Arch Biochem Biophys 299: 302-312, 1992.
22. Gorbunov NV, Osipov AN, Day BW, Zayas-Rivera B, Kagan VE, and Elsayed NM. Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide: a protective mechanism against ferryl hemoprotein-induced oxidations. Biochemistry 34: 6689-6699, 1995.
23. Gorbunov NV, Yalowich JC, Gaddam A, Thampatty P, Ritov VB, Kisin ER, Elsayed NM, and Kagan VE. Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence. J Biol Chem 272: 12328-12341, 1997.
24. Gorbunov NV, Tyurina YY, Salama G, Day BW, Claycamp HG, Argyros G, Elsayed NM, and Kagan VE. Nitric oxide protects cardiomyocytes against tert-butyl hydroperoxide-induced formation of alkoxyl and peroxyl radicals and peroxidation of phosphatidylserine. Biochem Biophys Res Commun 244: 647-651, 1998.
25. Gunther MR, Sturgeon BE, and Mason RP. A long-lived tyrosyl radical from the reaction between horse metmyoglobin and hydrogen peroxide. Free Radic Biol Med 28: 709-719, 2000.
26. Guo B, Brown FM, Phillips JD, Yu Y, and Leibold EA. Characterization and expression of iron regulatory protein 2 (IRP2). Presence of multiple IRP2 transcripts regulated by intracellular iron levels. J Biol Chem 270: 16529-16535, 1995.
27. Halliwell B, and Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1-14, 1984.
28. Hentze MW, Caughman SW, Rouault TA, Barriocanal JG, Dancis A, Harford JB, and Klausner RD. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238: 1570-1573, 1987.
29. Herbert V, Shaw S, Jayatilleke E, and Stopler-Kasdan T. Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12: 289-303, 1994.
30. Hirling H, Henderson BR, and Kuhn LC. Mutational analysis of the [4Fe-4S]-cluster converting iron regulatory factor from its RNA-binding form to cytoplasmic aconitase. EMBO J 13: 453-461, 1994.
31. Hogg N, Kalyanaraman B, Joseph J, Struck A, and Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett 334: 170-174, 1993.
32. Hogg N, Rice-Evans C, Darley-Usmar V, Wilson MT, Paganga G, and Bourne L. The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. Arch Biochem Biophys 314: 39-44, 1994.
33. Iakutova ES, Osipov AN, Kostenko OV, Arnkhol'd I, Arnol'd K, and Vladimirov IuA. Interaction of hypochlorite with oxyhemoglobin leads to liberation of iron in a catalytically active form. [Russian] Biofizika 37: 1021-1028, 1992.
34. Iannone A, Tomasi A, and Canfield LM. Generation of N-tert-butyl-alpha-phenylnitrone radical adducts in iron breakdown of tert-butyl-hydroperoxide. Res Chem Intermed 22: 469-479, 1996.
35. Irwin JA, Ostdal H, and Davies MJ. Myoglobin-induced oxidative damage: evidence for radical transfer from oxidized myoglobin to other proteins and antioxidants. Arch Biochem Biophys 362: 94-104, 1999.
36. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood 50: 433-439, 1977.
37. Jacobs DL, Watt GD, Frankel RB, and Papaefthymiou GC. Redox reactions associated with iron release from mammalian ferritin. Biochemistry 28: 1650-1655, 1989.
38. Jinno J, Shigematsu M, Tajima K, Sakurai H, Ohya Nishiguchi H, and Ishizu K. Coordination structure and chemical reactivity of hemoprotein-butyl peroxide complex. Biochem Biophys Res Commun 176: 675-681, 1991.
39. Kang JH, and Kim SM. Fragmentation of human Cu,Zn-superoxide dismutase by peroxidative reaction. Mol Cells 7: 553-558, 1997.
40. Kanner J, Harel S, and Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 289: 130-136, 1991.
41. Ke Y, Wu J, Leibold EA, Walden WE, and Theil EC. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J Biol Chem 273: 23637-23640, 1998.
42. Kim YM, Bergonia HA, Muller C, Pitt BR, Watkins WD, and Lancaster JR Jr. Nitric oxide and intracellular heme. Adv Pharmacol 34: 277-291, 1995.
43. Korytowski W, Zareba M, and Girotti AW. Nitric oxide inhibition of free radical-mediated cholesterol peroxidation in liposomal membranes. Biochemistry 39: 6918-6928, 2000.
44. Kozlov AV, Vladimirov IuA, and Azizova OA. The measurement of the amount of iron (III) complexes with desferal in the perfused rat liver by an EPR method. [Russian] Biull Eksp Biol Med 107: 577-579, 1989.
45. Kozlov AV, Yegorov DY, Vladimirov YA, and Azizova OA. Intracellular free iron in liver tissue and liver homogenate: studies with electron paramagnetic resonance on the formation of paramagnetic complexes with desferal and nitric oxide. Free Radic Biol Med 13: 9-16, 1992.
46. Loew GH, and Harris DL. Role of the heme active site and protein environment, structure, spectra, and function of the cytochrome P450s. Chem Rev 100:407-419, 2000
47. McArthur KM, and Davies MJ. Detection and reactions of the globin radical in hemoglobin. Biochim Biophys Acta 1202: 173-181, 1993.
48. Mehlhorn RJ, and Gomez J. Hydroxyl and alkoxyl radical production by oxidation products of metmyoglobin. Free Radic Res Commun 18: 29-41, 1993.
49. Menotti E, Henderson BR, and Kuhn LC. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J Biol Chem 273: 1821-1824, 1998.
50. Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, and Roberts LJ. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-in-duced renal failure. J Biol Chem 273: 31731-31737, 1998.
51. Ostdal H, Andersen HJ, and Davies MJ. Formation of long-lived radicals on proteins by radical transfer from heme enzymes - a common process? Arch Biochem Biophys 362: 105-112, 1999.
52. Panter SS. Release of iron from hemoglobin. Methods Enzymol 231: 502-514, 1994.
53. Pantopoulos K, and Hentze MW. Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc Natl Acad Sci U S A 92: 1267-1271, 1995.
54. Paraskeva E, and Hentze MW. Iron-sulphur clusters as genetic regulatory switches: the bifunctional iron regulatory protein-1. FEES Lett 389: 40-43, 1996.
55. 2 yields persistent ferryl iron and protein based radicals. Free Radic Res 25: 117-123, 1996.
56. Rafferty SP, Domachowske JB, and Malech HL. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line. Blood 88: 1070-1078,1996.
57. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 12: 417-427, 1992.
58. Richardson DR, and Ponka P. Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism. Am J Hematol 58: 299-305, 1998.
59. Ritke MK, Roberts D, Allan WP, Raymond J, Bergottz W, and Yalowich JC. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukemia K562 cells. Br J Cancer 69: 687-697, 1994.
60. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, and Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269: 26066-26075, 1994
61. Samaniego F, Chin J, Iwai K, Rouault TA, and Klausner RD. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem 269: 30904-30910, 1994.
62. Shvedova AA, Tyurina YY, Gorbunov NV, Tyurin VA, Castranova V, Kommineni C, Ojimba J, Gandley R, McLaughlin MK, and Kagan VE. tert-Butyl hydroperoxide/hemoglobin-induced oxidative stress and damage to vascular smooth muscle cells: different effects of nitric oxide and nitrosothiols. Biochem Pharmacol 57: 989-1001, 1999.
63. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, and Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 26: 85-89, 1998.
64. Stamler JS, Singel DJ, and Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992.
65. Stolze K, and Nohl H. Reactions of reducing xenobiotics with oxymyoglobin. Formation of metmyoglobin, ferryl myoglobin and free radicals: an electron spin resonance and chemiluminescence study. Biochem Pharmacol 49: 1261-1267, 1995.
66. Svistunenko DA, Patel RP, and Wilson MT. An EPR investigation of human methaemoglobin oxidation by hydrogen peroxide: methods to quantify all paramagnetic species observed in the reaction. Free Radic Res 24: 269-280, 1996.
67. Tajima K. A possible model of a hemoprotein-hydrogen peroxide complex. Inorg Chim Acta 163: 115-122, 1989.
68. Theil EC. Iron regulatory elements (IREs): a family of mRNA non-coding sequences. Biochem J 304: 1-11, 1994.
69. Thomson AM, Rogers JT, and Leedman PJ. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol 31: 1139-1152, 1999.
70. Vanin AF, and Chetverikov AG. Paramagnetic nitrosyl complexes of heme and nonheme iron. [Russian] Biofizika 13: 608-615, 1968.
71. Vanin AF, Bliumenfel'd LA, and Chetverikov AG. EPR study of non-heme iron complexes in cells and tissues. [Russian] Biofizika 12: 829-838, 1967.
72. Yalowich JC, Gorbunov NV, Kozlov AV, Allan W, and Kagan VE. Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells. Biochemistry 38: 10691-10698, 1999.
73. Yamakura F, Rardin RL, Petsko GA, Ringe D, Hiraoka BY, Nakayama K, Fujimura T, Taka H, and Murayama K. Inactivation and destruction of conserved Trp159 of Fe-superoxide dismutase from Porphyromonas gingivalis by hydrogen peroxide. Eur J Biochem 253: 49-56, 1998.